Journal
NATURE REVIEWS NEUROSCIENCE
Volume 16, Issue 5, Pages 264-277Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrn3937
Keywords
-
Categories
Funding
- US National Institutes of Health grant [NS74432]
- Ministry of Education, Culture, Sports, Science and Technology of Japan [23500466, 25000015]
- Grants-in-Aid for Scientific Research [25000015, 23500466] Funding Source: KAKEN
Ask authors/readers for more resources
Endocannabinoids are lipid-derived messengers, and both their synthesis and breakdown are under tight spatiotemporal regulation. As retrograde signalling molecules, endocannabinoids are synthesized postsynaptically but activate presynaptic cannabinoid receptor 1 (CB1) receptors to inhibit neurotransmitter release. In turn, CB1-expressing inhibitory and excitatory synapses act as strategically placed control points for activity-dependent regulation of dynamically changing normal and pathological oscillatory network activity. Here, we highlight emerging principles of cannabinoid circuit control and plasticity, and discuss their relevance for epilepsy and related comorbidities. New insights into cannabinoid signalling may facilitate the translation of the recent interest in cannabis-related substances as antiseizure medications to evidence-based treatment strategies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available